Positive modulation of endogenous AnxA1 in inflammatory cells in the eyes of mice and retinal pigment epithelial cells (ARPE-19) infected with Toxoplasma gondii suggests the protein can be used as a therapeutic target in ocular toxoplasmosis [30]. Here, ANXA1 is linked to ocular toxoplasmosis.